Quantitative structure-activity relationships of antihypertensive agents

Progress in Drug Research

Volumn 53, Issue , 1999, Pages 53-87

  Gupta, Satya P ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Antihypertensive agents; Arylquinolizines; Carbonic anhydrase inhibitors; Central agonists; Clonidines; Diuretics; Hypotensive agents; Imidazolidines; Peripheral antagonists; Platelet aggregation inhibitors; Potassium channel activators; Renin inhibitors; Sulfonamides; Sympatholytic agents; Vasodilators

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CARBONATE DEHYDRATASE INHIBITOR; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMIDAZOLINE DERIVATIVE; POTASSIUM CHANNEL STIMULATING AGENT; RENIN INHIBITOR; SULFONAMIDE; VASODILATOR AGENT;

HUMAN; HYDROPHOBICITY; HYPERTENSION; LIPOPHILICITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; STEREOCHEMISTRY;

EID: 0032725646     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0348-8735-9_2     Document Type: Review

References (112)

1. A.C. Guyton, T.G. Coleman, A.W. Cowley, R.D. Manning, Jr., R.A. Norman, Jr. and J.D. Ferguson: Circ. Res. 35, 159 (1974).
2. A.C. Guyton, D.B. Young, J.W. DeClue, J.D. Ferguson, R.E. McCaa, A.Gevise, N.C. Trippadoand J.E. Hall, in: G. Berglund, L.Hansson and L. Werkȯ (eds.,: Pathophysiology and Management of Arterial Hypertension, Astra Pharmaceuticals A.B., Sweden 1975, p. 78.
3. B. Folkow, M. Hallbäck, Y. Lundgren, R. Sivertsson and L. Weiss: Circ. Res. 32 (Suppl. I), 1-2 (1973).
4. M.J. Peach: Physiol. Rev. 57, 313 (1977).
5. M.A. Ondetti and D.W. Kushman : J. Med. Chem. 24, 355 (1981).
6. E.A. Murphy: Circ. Res. 32/33 (Suppl. I), I-129 (1973).
7. M. Thyes, H.D. Lehman, J. Gries, H. Konig, R. Kretzschmar, J. Kunze, R. Lebku̇cher and D. Lenke: J. Med. Chem. 26, 800 (1983).
8. S.P. Gupta, P. Singh and M.C. Bindal: Chem. Rev. 83, 633 (1983).
9. S.P. Gupta: Chem. Rev. 87, 1183 (1987).
10. S.P. Gupta: Chem. Rev. 89, 1765 (1989).
11. S.P. Gupta: Chem. Rev. 91, 1109 (1991).
12. S.P. Gupta: Chem. Rev, 94, 1507 (1994).
13. S.P. Gupta: Prog. Drug Res. 45, 67 (1995).
14. S.P. Gupta: Current Pharm. Des. 4, 455 (1998).
15. S.P. Gupta: Chem. Rev., communicated.
16. S.P. Gupta, H. Gao, R. Garg, M.S. Babu and C. Hansch: Chem. Rev., communicated.
17. P.B.M.W.M. Timmermans and P.A.van Zwieten: Eur. J. Pharmacol. 47, 391 (1977).
18. P.B.M.W.M. Timmermans, A. Brands and P.A. van Zwieten: Naunyn Schmiedebergs Arch. Pharmacol. 300, 217 (1977).
19. P.B.M.W.M. Timmermans and P.A. van Zwieten: J. Med. Chem. 20, 1636 (1977).
20. P.A. van Zwieten and P.B.M.W.M. Timmermans: Trends Pharmacol. Sci. 1, 39 (1979).
21. P.A. van Zwieten: Br. J. Clin. Pharmacol. 10, 135 (1980).
22. P.B.M.W.M. Timmermans: Proc. Pharmacol. 3, 25 (1980).
23. W. Hoefke, W. Kobinger and A. Walland: Arzneim.-Forsch. 25, 786 (1975).
24. A. Walland and W. Hoefke: Naunyn Schmiedebergs Arch. Pharmacol. 282, R104 (1974).
25. P.B.M.W.M.Timmermans and P.A.van Zwieten: Eur. J. Pharmacol. 45, 229 (1977).
26. P.B.M.W.M. Timmermans, A. De Jonge, J.C.A. van Meel, F.P. Slothorst-Grisdijk, E. Lam and P.A. van Zwieten: J. Med. Chem. 24, 502 (1981).
27. B. Belleau, in: K.J. Burnings (ed.): Proceedings of the First International Pharmacological Meeting, Stockholm 1961, Vol. 7, Pergamon Press, Oxford 1963, p. 75.
28. B. Bellaeu: Ann. NY Acad. Sci. 139, 580 (1967).
29. R.B. Barlow: Introduction to Chemical Pharmacology, 2nd ed., John Wiley, New York 1963.
30. B. Rouot, G. Leclerc, C.-G. Wermuth, F. Miesch and J. Schwartz: J. Med. Chem. 19, 1049 (1976).
31. B. Rouot, G. Leclerc, C.-G. Wermuth, F. Miesch and J. Schwartz: J. Pharmacol. 8, 95 (1977).
32. P.A. van Zwieten and P.B.M.W.M. Timmermans: Adv. Drug Res. 13, 209 (1984).
33. W. Kobinger and L. Pichler: Naunyn Schmiedebergs Arch. Pharmacol. 315, 21 (1980).
34. A. De Jonge, F.P. Slothorst-Grisdijk and P.B.M.W.M. Timmermans: Eur. J. Pharmacol. 71, 411 (1981).
35. A. De Jonge, P.B.M.W.M. Timmermans and P.A. van Zwieten: J. Pharmacol. Exp. Ther. 222, 705 (1982).
36. P.B.M.W.M. Timmermans, A. De Jonge, M.J.M.C. Thoolen, B. Wilffert, H. Batink and P.A. van Zwieten: J. Med. Chem. 27, 495 (1984).
37. J.R. Huff, J.J. Baldwin, S. DeSolms, J.P. Guare, Jr., C.A. Hunt, W.C. Randall, W.S. Sanders, S.J. Smith, J.P. Vacca and M.M. Zrada: J. Med. Chem. 31, 641 (1988).
38. J.D. Lee and E.J. Lien: Acta Pharm. Jugosl. 36, 211 (1986).
39. B. Pullman, J.L. Coubeils, P. Courriére and J.P. Gervois: J. Med. Chem. 15, 17 (1972).
40. J.L. Coubelis, P. Courriére and B. Pullman: J. Med. Chem. 15, 453 (1972).
41. C.-G. Wermuth, J. Schwartz, G. Leclerc, J.P. Gamier and B. Rouot: Clin. Ther. 1, 115 (1973).
42. W. Hoefke: ACS Symp. Ser. No. 27, 27 (1976).
43. C.M. Meerman-van Benthem, K. van der Meer, J.J.C. Mulder, P.B.M.W.M. Timmermans and P.A. van Zwieten: Mol. Pharmacol. 11, 667 (1975).
44. P.B.M.W.M. Timmermans, P.A. van Zwieten, C.M. Meerman-van Benthem, K. van der Meer and J.J.C. Mulder: Arzneim.-Forsch. 27, 2266 (1977).
45. A. Murti, K. Bhandari, S. Ram, Y.S. Prabhakar, A.K. Saxena, P.C. Jain, A.K. Gulati, R.C. Srimal, B.N. Dhawan, S. Nityanand and N. Anand: Indian J. Chem. 28B, 934 (1989).
46. A.K. Saxena, J. Rao, R.C. Srimal, E. Audry and A. Karpy: Indian J. Chem. 32B, 1249, (1993).
47. N. Sinha, S. Jain, M.P. Dubey, A.K. Saxena and N. Anand: Indian J. Chem. 35B, 213 (1996).
48. E. Audry, J.P. Dubost, Ph. Dallet, M.H. Langlois and J.C. Colleter: Eur. J. Med. Chem. 24, 155 (1989).
49. R.M. Graham, H.F. Oates, L.M. Stoker and G.S. Stoker J. Pharmacol. Exp. Ther. 201, 747 (1977).
50. J.C. McGrath: Biochem. Pharmacol. 31, 467 (1982)
51. F. Gross: Br. J. Clin. Pharmacol. 13 (Suppl. 1), 5 (1982).
52. G. Winters, A. Sala, D. Barone and E. Baldoli: J. Med. Chem. 28, 934 (1985).
53. P. Singh and R.C. Sharma: Quant. Struct.-Act. Relat. 9, 29 (1990).
54. A.A. Rubin, F.E. Roth, M.M, Winbury, J.G. Topliss, M.H. Sherlock, N. Sperber and J. Block: Science 133, 2067 (1961).
55. J.G. Topliss, M.H. Sherlock, H. Reimann, L.M. Konzelman, E.P. Shapiro, B.W. Petterson, H. Schneider and N. Sperber: J. Med. Chem. 6, 122 (1963).
56. J.G. Topliss, L.M. Konzelman, E.P. Shapiro, N. Sperber and F.E. Roth: J. Med. Chem. 7, 269 (1964).
57. F.C. Novello, S.C. Bell, E.L.A. Abrams, C. Ziegler and J.M. Sprague: J. Org. chem. 25, 970 (1960).
58. A. J. Wohl: Mol. Pharmacol. 6, 189 (1970).
59. J.G. Topliss and M.D. Yudis: J. Med. Chem. 15, 394 (1972).
60. A.J. Wohl, L.M. Hausler and F.E. Roth: J. Pharmacol. Exp. Ther. 158, 531 (1967).
61. A.A. Robin, F.E. Roth, R.M. Taylor and H. Rosenkilde: J. Pharmacol. Exp. Ther. 136, 344 (1962).
62. H. Horstmann, E. Moller, E. Wehinger and K. Meng: ACS Symp. Ser. No. 83, 125 (1978).
63. E. Mizuta, K. Nishikawa, K. Omura and Y.Oka: Chem. Pharm. Bull. 24, 2078 (1976).
64. P. Singh and S.P. Gupta: Indian J. Med. Res. 69, 804 (1979).
65. M.C. Bindal, Y.M. Chopra, P.Singh and S.P. Gupta: Indian J. Pharm. Sci. 43, 47 (1981).
66. G. Satzinger: Arzneim.-Forsch. 27, 1742 (1977).
67. N. Kakeya, M. Aoki, A. Kamada and N. Yata: Chem. Pharm. Bull. 17, 1010 (1969).
68. N. Kakeya, N. Yata, A. Kamada and M. Aoki: Chem. Pharm. Bull. 17, 2000 (1969).
69. N. Kakeya, N. Yata, A. Kamada and M. Aoki: Chem. Pharm. Bull. 17, 2558 (1969).
70. N. Kakeya, N. Yata, A. Kamada and M. Aoki: Chem. Pharm. Bull. 18, 191 (1970).
71. E.J. Lien, M. Hussain and G.L. Tong: J. Pharm. Sci. 59, 865 (1970).
72. R.W. King and A.S. Burgen: Proc. Roy. Soc. London B 193, 107 (1976).
73. C. Hansch, J. McClarin and R. Langridge: Mol. Pharmacol. 27, 493 (1985).
74. K. Kumar, M.C. Bindal, P. Singh and S.P. Gupta: Int. J. Quantum Chem. 20, 123 (1981).
75. K.K. Kannan, in: R. Srinivasan (ed.): Biomolecular Structure, Conformation, Function and Evaluation, Vol. 1, Pergamon Press, Oxford, New York 1980, p. 165.
76. S. Lindskog, L.E. Henderson, K.K. Kannan, A. Liljas, P.O. Nyman and B. Strandberg, in: P.D. Boyer (ed.): The Enzymes, 3rd ed., Vol. 5, Academic Press, New York 1971, p. 587.
77. K.K. Kannan, I. Waara, B. Notstrand, S. Lovgren, A. Borell, K. Fridborg and M. Petef, in: G.C.K. Roberts (ed.): Drug Action at the Molecular Level, University Park Press, Baltimore 1977, p. 73.
78. J.E. Coleman: Annu. Rev. Pharmacol. Toxicol. 15, 221 (1975).
79. A. Vedani and F.E. Meyer, Jr.: J. Pharm. Sci. 73, 352 (1984).
80. Y. Shinagawa and Y. Shinagawa: Int. J. Quantum Chem., Quantum Biol. Symp. No. 1, 169 (1974).
81. H.A. Krebs: Biochem. J. 43, 525 (1984).
82. S.N. Subbarao and P.Bray: J. Med. Chem. 22, 111 (1979).
83. P.G. De Benedetti, M.C. Menziani and C. Frassineti: Quant. Struct.-Act. Relat. 4, 23 (1985).
84. P.G. De Benedetti, M. C. Menziani, M. Cocchi and C. Frassineti: Quant. Struct.-Act. Relat. 6, 51 (1987).
85. M.C. Menziani, P.G. De Bendetti, F. Gago and W.G. Richards: J. Med. Chem. 32, 951 (1989).
86. B. Testa and W.P. Purcell: Eur. J. Med. Chem. 13, 509 (1978).
87. A.J. Wohl: Mol. Pharmacol. 6, 195 (1970).
88. G. Leclerc, C.-G. Wermuth, F. Miesch and J. Schwartz: Eur. J. Med. Chem. 11, 107 (1976).
89. A. Gangjee, H.P.C. Hogencamp and J.M. Kitzen: J. Pharm. Sci. 67, 121 (1978).
90. M.C. Bindal, P. Singh, R.P. Bhatnagar and S.P. Gupta: Arzeim.-Forsch. 30, 924 (1980).
91. W.P. Heilman, R.D. Heilman, J. A. Scozzie, R.J. Wayner, J.M. Gullo and Z.S. Ariyan: J. Med. Chem. 22, 671 (1979).
92. G. Edwards and A.H. Weston: Trends Pharm. Sci. 11, 417 (1990).
93. D.G. Smith: J. Chem. Soc., Perkin Trans, 1, 3187 (1990).
94. G. Burrel, F. Cassidy, J.M. Evans, D. Lightowler and G. Stemp: J. Med. Chem. 33, 3023 (1990).
95. M.R. Attwood: Current Drugs: Potassium Channel Modulators KCK-B 39 (1991).
96. P.J. Sanfilippo, J.J. McNally, J.B. Press, L.J. Fitzpatrick, M. Urbanski, L.J. Katz, E. Giardino, R. Falotico and J. Salata: J. Med. Chem. 35, 4425 (1992).
97. V.A. Ashwood, F. Cassidy, J.M. Evans, S. Gagliardi and G. Stemp: J. Med. Chem. 34, 3261 (1991).
98. D.R. Buckle, D.S. Eggleston, C.S.V. Houge-Frydrych, I. Pinto, S.A. Readshaw, D.G. Smith and R.A.B. Webster: J. Chem. Soc., Perkin Trans, 1, 2763 (1991).
99. C. Almansa, L.A. Gomez, F.L. Cavalcanti, R. Rodriguez, E. Carceller, J. Bartrol, J. Garcia-Rafanell and J. Forn: J. Med. Chem. 36, 2121 (1993).
100. P.W. Manley, U. Quast, H. Andres and K. Bray: J. Med. Chem. 36, 2004 (1993).
101. K.S. Atwal, G.J. Grover, N.J. Lodge, D.E. Normandin, S.C. Traeger, P.G. Sleph, R.B. Cohen, C.C. Bryson and K.E.J. Dickinson: J. Med. Chem. 41, 271 (1998).
102. M.E. Condon, E.W. Petrillo, Jr., D.E. Ryono, J.A. Reid, R. Neubeck, M. Puar, J.E. Heikes. E.F. Sabo, K.E. Losee, D.W. Kushman and M.A. Ondetti: J. Med. Chem. 25, 250 (1982).
103. Y.S. Prabhakar and S.P. Gupta: Indian J. Biochem. Biophys. 22, 318 (1985).
104. W.W. Petrillo, N.C. Trippodo and J.M. DeForrest: Annu. Rep. Med. Chem. 25, 51 (1990).
105. D.G. Hangauer, in: T.J. Perun and C.L. Propst (eds.): Computer-Aided Drug Design: Methods and Applications, Marcel Dekker, New York 1989, p. 253.
106. M.R, Saunders, M.S. Tute and G.A. Web: J. Comput.-Aided Mol. Des. 1, 133 (1987).
107. D. Mayer, C.B. Naylor, I. Motoc and G.R. Marshall: J. Comput.-Aided Mol. Des. 1, 3 (1987).
108. C.L. Waller and G.R. Marshall: J. Med. Chem. 36, 2390 (1993).
109. S.P. Gupta, J.K. Gupta, A.N. Nagappa, V. Jagannathan and D. Gangwal: Drug Des. Deliv. 5, 73 (1989).
110. D. Nisato, J. Wagnon, G. Callet, D. Mettefeu, J.-L. Assens, C. Plouzane, B. Tonnerre, V. Pliska and J.-L. Fauchère: J. Med. Chem. 30, 2287 (1987).
111. M. Thyes, H.D. Lehman, J. Gries, H. Konig, R. Kretzschmar, J. Kunze, R. Lebkucher and D. Lenke: J. Med. Chem. 26, 800 (1983).
112. S.P. Gupta, D.G. Shewade, C. Garg, A, Handa and Y.S. Prabhakar: Indian J. Biochem. Biophys. 22, 122 (1985).